-
Mashup Score: 10VeloSano reveals 2023 Bike to Cure event raises more than $14.3 million to benefit cancer research at Cleveland Clinic - 6 month(s) ago
And they’re not done yet! VeloSano 2024 is scheduled to take place Sept. 6-7.
Source: www.wkyc.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 10VeloSano reveals 2023 Bike to Cure event raises more than $14.3 million to benefit cancer research at Cleveland Clinic - 6 month(s) ago
And they’re not done yet! VeloSano 2024 is scheduled to take place Sept. 6-7.
Source: www.wkyc.comCategories: General Medicine News, Hem/OncsTweet-
RT @wkyc: AMAZING! @bikeVeloSano has just revealed this year's fundraising total -- and it's absolutely incredible! https://t.co/5cx1u7aUAk…
-
-
Mashup Score: 2Home | VeloSano - 8 month(s) ago
Latin for “swift cure,” VeloSano is Cleveland Clinic’s premier fundraising initiative in which 100% of every dollar raised supports lifesaving cancer research at Cleveland Clinic and Cleveland Clinic Children’s. Since its inception in 2014, over $37 million has been raised and has advanced over 200 cancer research projects.
Source: velosano.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
Another year starting @bikeVeloSano with @DrJohnSuh! About to start VeloSano 10. Already $4.5 million raised! That’s 100% for innovative #cancer research. https://t.co/6xY7zg0GTy. https://t.co/bmekdMxmsR
-
-
Mashup Score: 1Fundraising for VeloSano - 10 month(s) ago
Support cancer research at Cleveland Clinic through VeloSano 10!
Source: ClassyCategories: Hem/Oncs, Latest HeadlinesTweet-
The 4th of July! A day to be grateful for freedom. Let’s work on freedom from #cancer. I will ride 50 miles this fall during @bikeVeloSano to raise money for innovative cancer research @ClevelandClinic. Click the link to learn more and donate. https://t.co/j8kqXH9EQL https://t.co/M6zq1geVfW
-
-
Mashup Score: 0Ide-CEL CAR T-Cell Therapy Effective in Multiple Myeloma Among Patients with Comorbidities - 11 month(s) ago
We discuss ide-CEL CAR T-cell therapy and its effectiveness in multiple myeloma patients.
Source: Cleveland ClinicCategories: Hem/Oncs, Latest HeadlinesTweet-
This week on the @ClevelandClinic Cancer Advances podcast, I talk to @CleClinicMD Jack Khouri (@khouri_jack), a hematologist specializing in plasma cell disorders about using Ide-CEL CAR T-cell therapy for patients with multiple myeloma and comorbidities https://t.co/yXPkOi7gQl
-
-
Mashup Score: 5Fundraising for VeloSano - 11 month(s) ago
Support cancer research at Cleveland Clinic through VeloSano 10!
Source: ClassyCategories: Hem/Oncs, Latest HeadlinesTweet-
Why the bike-themed tie today? 100 days until Bike to Cure weekend where I’ll ride 50 miles during @bikeVeloSano 10 to raise $$$ for innovative cancer research @ClevelandClinic! Click the link to learn more and donate. https://t.co/j8kqXH9EQL. https://t.co/bVHgdu9Esr
-
-
Mashup Score: 0Monoclonal Gammopathy of Undetermined Significance (MGUS) - 12 month(s) ago
Sandra Mazzoni talks about monoclonal gammopathy of undetermined significance.
Source: Cleveland ClinicCategories: Hem/Oncs, Latest HeadlinesTweet-
This week on the @ClevelandClinic Cancer Advances podcast, I talk to @CleClinicMD Sandra Mazzoni talks about management of monoclonal gammopathy of undetermined significance (MGUS) https://t.co/1GXDMD9KTA
-
-
Mashup Score: 3Novel Therapeutics Clinic - 1 year(s) ago
We discuss the importance of novel therapeutics and its clinic.
Source: Cleveland ClinicCategories: Hem/Oncs, Latest HeadlinesTweet-
This week on the @ClevelandClinic Cancer Advances podcast, I talk to @CleClinicMD Alex Adjei, Chair Taussig Cancer Institute, about clinical research on new cancer treatments in our new novel therapeutics clinic https://t.co/ByHCu3K1Sv
-
-
Mashup Score: 5
Emrullah Yilmaz discusses new ASCO guidelines.
Source: Cleveland ClinicCategories: Hem/Oncs, Latest HeadlinesTweet-
This week on the @ClevelandClinic Cancer Advances podcast, I talk to @CleClinicMD Emrullah Yilmaz (@YilmazMDPhD), Assoc Director Precision Oncology about new @ASCO guidelines for managing patients with recurrent and metastatic head and neck cancers. https://t.co/VgJeRUoav5
-
-
Mashup Score: 1Insights into the MOMENTUM Trial - 1 year(s) ago
Aaron Gerds talks about the MOMENTUM trial.
Source: Cleveland ClinicCategories: Hem/Oncs, Latest HeadlinesTweet-
This week on the @ClevelandClinic Cancer Advances podcast, I talk to @CleClinicMD @AaronGerds hematologist and Deputy Dir Clinical Research at Taussig about myelofibrosis, current JAK inhibitors and new therapies including data from the MOMENTUM Trial https://t.co/0jbs0tBclC
-
RT @wkyc: AMAZING! @bikeVeloSano has just revealed this year's fundraising total -- and it's absolutely incredible! https://t.co/5cx1u7aUAk…